Ryushi Tazawa Selected Research

Ryushi Tazawa Research Topics

Disease

25	Pulmonary Alveolar Proteinosis 01/2023 - 05/2005
6	Fabry Disease (Fabry's Disease) 06/2021 - 04/2013
6	Neoplasms (Cancer) 02/2012 - 01/2002
3	Lung Diseases (Lung Disease) 01/2021 - 01/2017
2	Pneumonia (Pneumonitis) 12/2023 - 11/2016
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 10/2017 - 11/2016
2	Infections 08/2015 - 07/2004
2	Acquired Pulmonary Alveolar Proteinosis 11/2009 - 04/2008
2	Lung Neoplasms (Lung Cancer) 07/2004 - 02/2002
1	Viral Pneumonia 12/2023
1	COVID-19 12/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Inflammation (Inflammations) 01/2018
1	Stomatitis 10/2017
1	Rare Diseases (Rare Disease) 08/2017
1	Disease Progression 11/2016
1	Hypoxia (Hypoxemia) 04/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004
1	Respiratory Sounds (Crackle) 04/2003
1	Hypoparathyroidism 04/2003
1	Lewis Lung Carcinoma 07/2002
1	Neoplasm Metastasis (Metastasis) 02/2002
1	Adenocarcinoma 01/2002

Drug/Important Bio-Agent (IBA)

22	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023 - 05/2005
11	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 02/2012
11	AutoantibodiesIBA 01/2019 - 05/2005
8	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2006
5	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2015
5	globotriaosyl lysosphingolipidIBA 08/2019 - 04/2013
5	Proteins (Proteins, Gene)FDA Link 08/2017 - 02/2002
3	sargramostim (Leukine)FDA Link 12/2023 - 01/2018
3	GalactosidasesIBA 06/2021 - 04/2013
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2010
3	CytokinesIBA 01/2017 - 07/2002
2	SteroidsIBA 12/2023 - 04/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 08/2015
2	Sirolimus (Rapamycin)FDA Link 10/2017 - 11/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2002 - 02/2002
2	Angiogenesis InhibitorsIBA 07/2002 - 02/2002
1	Smad7 ProteinIBA 01/2022
1	Mitochondrial Uncoupling ProteinsIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Oxygen (Dioxygen)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	lipoarabinomannan (LAM)IBA 11/2016
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2013
1	EnzymesIBA 04/2013
1	Immunoglobulin M (IgM)IBA 05/2012
1	Interleukin-17 (Interleukin 17)IBA 02/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 08/2010
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 04/2008
1	Carbon MonoxideIBA 04/2008
1	Interleukin-12 (IL 12)IBA 01/2005
1	InterleukinsIBA 01/2005
1	VaccinesIBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 01/2005
1	Secretory Leukocyte Peptidase InhibitorIBA 07/2004
1	Vitamin D FDA LinkGeneric 04/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2002
1	Messenger RNA (mRNA)IBA 07/2002
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2002
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 07/2002
1	Peptides (Polypeptides)IBA 02/2002
1	matrigelIBA 02/2002
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2002
1	ProstaglandinsIBA 01/2002
1	Arachidonic Acid (Vitamin F)IBA 01/2002
1	Prostaglandins DIBA 01/2002
1	Prostaglandins EIBA 01/2002
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2002
1	ThromboxanesIBA 01/2002
1	Complementary DNA (cDNA)IBA 01/2002

Therapy/Procedure

7	Therapeutics 11/2016 - 02/2002
3	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2006
1	Subcutaneous Injections 04/2014
1	Immunotherapy 01/2005
1	Intraperitoneal Injections 02/2002